Aspivix is modernizing gynecology with carevix®, the only clinically proven, non-traumatic alternative to the cervical tenaculum used during intrauterine device (IUD) procedures.
This overview is generated using artificial intelligence based on information available
on the platform’s project page and publicly accessible data. It is provided for
informational purposes only and does not constitute investment advice, financial
guidance, risk assessment, or project scoring. Platforms and project owners are not
involved in the creation, review, or endorsement of this content.
AI project overview
Condensed summary based on project data
<h1><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">Aspivix SA — Crowdfunding Investor Memo</span></span></h1>
<p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif"><em>A medical-device company selling a gentle, suction-based tool (carevix®) that doctors use to hold the cervix steady during coil (IUD) fittings and similar procedures — replacing a sharp clamp that often causes pain.</em></span></span></p>
<p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif"><strong>Sector: </strong>Medical devices (women’s health) · <strong>Stage: </strong>Series B2, first closing · <strong>HQ: </strong>Epalinges, Switzerland · <strong>Raise: </strong>€675,545 target (max €3,999,998)</span></span></p>
<h2><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">Snapshot</span></span></h2>
<table cellspacing="0" class="Table" style="border-collapse:collapse; border-color:currentcolor; border-image:none; border-style:none; border-width:medium">
<tbody>
<tr>
<td style="background-color:#f4f2ec; border-bottom:1px solid #cccccc; border-left:1px solid #cccccc; border-right:1px solid #cccccc; border-top:1px solid #cccccc; vertical-align:top; width:227px">
<p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif"><strong><span style="color:black">1 · Is the price fair? 💶</span></strong></span></span></p>
</td>
<td style="background-color:#faece7; border-bottom:1px solid #cccccc; border-left:none; border-right:1px solid #cccccc; border-top:1px solid #cccccc; vertical-align:top; width:397px">
<p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif"><strong><span style="color:black">2 / 5</span></strong><span style="color:black"> — stretched. The €26.3M asking value is about 80 times last year’s revenue, while the similar businesses the company lists were sold at about 6.9 times revenue. Not supported by the exit benchmarks we could find.</span></span></span></p>
</td>
</tr>
<tr>
<td style="background-color:#f4f2ec; border-bottom:1px solid #cccccc; border-left:1px solid #cccccc; border-right:1px solid #cccccc; border-top:none; vertical-align:top; width:227px">
<p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif"><strong><span style="color:black">2 · Can they reach an exit stage? ⭐</span></strong></span></span></p>
</td>
<td style="background-color:#faeeda; border-bottom:1px solid #cccccc; border-left:none; border-right:1px solid #cccccc; border-top:none; vertical-align:top; width:397px">
<p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif"><strong><span style="color:black">AI SCORE 73 / 100 — Good</span></strong><span style="color:black"> — the building blocks for reaching a sale are largely in place (approved in five markets, real sales, named buyers with a track record of similar purchases); the main gap is that sales are still small and cash runway was not in the pack.</span></span></span></p>
</td>
</tr>
<tr>
<td style="background-color:#f4f2ec; border-bottom:1px solid #cccccc; border-left:1px solid #cccccc; border-right:1px solid #cccccc; border-top:none; vertical-align:top; width:227px">
<p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif"><strong><span style="color:black">3 · If they do, what could it pay? 🎯</span></strong></span></span></p>
</td>
<td style="background-color:#f0f4f8; border-bottom:1px solid #cccccc; border-left:none; border-right:1px solid #cccccc; border-top:none; vertical-align:top; width:397px">
<p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif"><span style="color:black">Target 4x–7x over ~2–3+ years (the company’s own plan). If reached, that implies a sale of roughly €105M–€185M — within the range of past sales recorded in this sector ($44M to $1.6B). Illustrative only, before fees and future dilution.</span></span></span></p>
</td>
</tr>
</tbody>
</table>
<p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif"><strong>How to read the score</strong></span></span></p>
<table cellspacing="0" class="Table" style="border-collapse:collapse; border-color:currentcolor; border-image:none; border-style:none; border-width:medium">
<tbody>
<tr>
<td style="background-color:#d9ebc2; border-bottom:1px solid #cccccc; border-left:1px solid #cccccc; border-right:1px solid #cccccc; border-top:1px solid #cccccc; vertical-align:top; width:173px">
<p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif"><strong><span style="color:black">85–100 · Excellent</span></strong></span></span></p>
</td>
<td style="border-bottom:1px solid #cccccc; border-left:none; border-right:1px solid #cccccc; border-top:1px solid #cccccc; vertical-align:top; width:451px">
<p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif">All key building blocks for reaching a sale are evidenced and strong — rare at this stage.</span></span></p>
</td>
</tr>
<tr>
<td style="background-color:#faeeda; border-bottom:1px solid #cccccc; border-left:1px solid #cccccc; border-right:1px solid #cccccc; border-top:none; vertical-align:top; width:173px">
<p><span style="font-size:10pt"><span style="font-family:"Times New Roman",serif"><strong><span style="color:black">70–84 · Good</span></strong></span></span></p>
</td>
<td style="border-bottom:1px s
…
Equity crowdfunding
